InvestorsHub Logo
Post# of 251706
Next 10
Followers 22
Posts 3636
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Saturday, 03/09/2024 6:10:23 AM

Saturday, March 09, 2024 6:10:23 AM

Post# of 251706
Enanta Pharmaceuticals PATENTS new compounds for HBV and HDV - MARCH 9, 2024

Enanta Pharmaceuticals Inc. has disclosed new fused heterobicyclic derivatives reported to be useful for the treatment of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections.

https://www.bioworld.com/topics/520-bioworld-science

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.